PopulationsHumans

Trends in Antidiabetic Medication Use among California Medicare Beneficiaries, 2013–2022

ADA Scientific Sessions 2026 Abstract

The paper

Jiahui Dai, Wenjun Fan, Yuxi Shi,

María M. Corrada, Annie Ro, Spero M. Manson, Joan Oconnell,

University of California, Irvine

ADA Scientific Sessions 2026 Abstract · 5 Jun 2026

Presented at ADA Scientific Sessions 2026 · Poster 1674-P

doi.org/10.2337/db26-1674-p

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Diabetes, Obesity & Metabolism · 8 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Drug Design, Development and Therapy · 5 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026